Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
pharmaceutical_companies:intradigm [2023/03/05 02:01]
liam [Personnel]
pharmaceutical_companies:intradigm [2024/11/09 19:40] (current)
liam [External links]
Line 16: Line 16:
  
 On November 22, 2002, Itradigm announced it had hired former [[Novavax]] CEO [[:John Spears]] as its Chairman and CEO.((//Ex-chief of Novavax hired as Intradigm CEO.// (2002, November 28). The Baltimore Sun, C2. https://www.newspapers.com/image/248431447/?terms=Intradigm&match=1)) ((//Intradigm appoints John A. Spears Chairman and CEO.// (2002, December 2). PharmaBiz. https://archive.ph/oRzIK)) On November 22, 2002, Itradigm announced it had hired former [[Novavax]] CEO [[:John Spears]] as its Chairman and CEO.((//Ex-chief of Novavax hired as Intradigm CEO.// (2002, November 28). The Baltimore Sun, C2. https://www.newspapers.com/image/248431447/?terms=Intradigm&match=1)) ((//Intradigm appoints John A. Spears Chairman and CEO.// (2002, December 2). PharmaBiz. https://archive.ph/oRzIK))
 +
 +On December 16, 2009, Intradigm was acquired by [[Silence Therapeutics]].((//Intradigm Corporation - Crunchbase Company Profile & Funding.// Crunchbase. Retrieved March 5, 2023, from https://www.crunchbase.com/organization/intradigm-corporation))
  
 ===== Organization ===== ===== Organization =====
Line 21: Line 23:
 ==== Funding ==== ==== Funding ====
  
-Investors in Intradigm include:((Bodnar, T. (2002). //Venture Capital Funds Annual Report July 2002 (p. 27).// Maryland Department of Business & Economic Development. https://web.archive.org/web/20230304190817/https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/000000/000115/unrestricted/20030190e.pdf))+Investors in Intradigm include:((Bodnar, T. (2002). //Venture Capital Funds Annual Report July 2002 (p. 27).// Maryland Department of Business & Economic Development. https://web.archive.org/web/20230304190817/https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/000000/000115/unrestricted/20030190e.pdf)) ((//Intradigm Corporation - Funding, Financials, Valuation & Investors.// Crunchbase. Retrieved March 5, 2023, from https://crunchbase.com/organization/intradigm-corporation/company_financials))
  
 +  * [[:Alta Partners]]
 +  * [[:Astellas Venture Management]]
 +  * [[Eli Lilly]]
   * [[:Emerging Technology Parters]]   * [[:Emerging Technology Parters]]
 +  * [[:Frazier Healthcare Partners]]
   * [[:Maryland Venture Fund]]   * [[:Maryland Venture Fund]]
 +  * [[:MediBIC Group]]
 +  * [[:MP Healthcare Venture Management]]
   * [[:Novartis Venture Fund]]   * [[:Novartis Venture Fund]]
 +  * [[:Roche Venture Fund]]
 ==== Personnel ==== ==== Personnel ====
  
Line 50: Line 58:
 | [[:Joel Cohen]]  | Member  | [[:University of the Pacific]]  | | [[:Joel Cohen]]  | Member  | [[:University of the Pacific]]  |
 | [[:Joel Jessee]]  | Member  | Vice President of [[Atto Bioscience]]  | | [[:Joel Jessee]]  | Member  | Vice President of [[Atto Bioscience]]  |
- +| [[:Hamid Ghandehari]]  | Member  | [[:University of Maryland at Baltimore]]  | 
 +| [[:Archibald James Mixson]]  | Member  | [[:University of Maryland at Baltimore]]  |
  
 ===== External links ===== ===== External links =====
  
 +  * [[https://wiki.whiteroseintelligence.com/en/Intradigm|Campfire Wiki]]
   * [[https://sites.google.com/housatonicits.com/home0004/research/intradigm-corp|Housatonic]]   * [[https://sites.google.com/housatonicits.com/home0004/research/intradigm-corp|Housatonic]]
Back to top